Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXSB2200001 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | Supplementary Application | 2022-01-07 | Betta Pharmaceuticals Co Ltd | view | |||
CXSL2300322 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | New Drug Application | 2023-05-09 | Betta Pharmaceuticals Co Ltd | view | |||
CXSL2400603 | 注射用MCLA-129 | MCLA-129 | Lyophilized | Biological Products(1) | New Drug Application | 2024-09-11 | Betta Pharmaceuticals Co Ltd | view |